# Correlative Analysis Between Magnetic Resonance Spectroscopy (MRS) and Essential Clinicobiological Data in Glioblatoma Multiforme (GBM)

> **NCT07211841** · NA · NOT_YET_RECRUITING · sponsor: **Centre Hospitalier Universitaire, Amiens** · enrollment: 30 (estimated)

## Conditions studied

- Glioblastoma
- MRI Spectroscopy
- Tumor Microenvironment
- Biomarkers / Blood

## Interventions

- **DEVICE:** MRS study
- **BIOLOGICAL:** blood samples

## Key facts

- **NCT ID:** NCT07211841
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12
- **Primary completion:** 2027-04
- **Final completion:** 2029-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07211841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07211841, "Correlative Analysis Between Magnetic Resonance Spectroscopy (MRS) and Essential Clinicobiological Data in Glioblatoma Multiforme (GBM)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07211841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*